ALZN vs. ORCL
ALZN (Alzamend Neuro, Inc.) and ORCL (Oracle Corporation) are both stocks. ALZN operates in Biotechnology (Healthcare), while ORCL operates in Software - Infrastructure (Technology). Over the past 5 years, ALZN returned -81.31%/yr vs 11.00%/yr for ORCL. Their 0.11 correlation means their historical movements had little consistent relationship.
Performance
ALZN vs. ORCL - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both stocks are quite close, with ALZN having a -26.37% return and ORCL slightly lower at -26.52%.
ALZN
- 1D
- 2.29%
- 1M
- 15.52%
- 6M
- -38.25%
- YTD
- -26.37%
- 1Y
- -39.09%
- 3Y*
- -86.60%
- 5Y*
- -81.31%
- 10Y*
- —
- ALL TIME*
- -86.51%
ORCL
- 1D
- 9.22%
- 1M
- 1.48%
- 6M
- -10.76%
- YTD
- -26.52%
- 1Y
- -41.30%
- 3Y*
- 8.69%
- 5Y*
- 11.00%
- 10Y*
- 14.88%
- ALL TIME*
- 21.74%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $51.91K | $67.44K | $173.62K | |
| $4.37B | $5.08B | $5.09B |
ALZN vs. ORCL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ALZN Alzamend Neuro, Inc. | -26.37% | -82.57% | -86.97% | -89.50% | -70.27% | -93.45% |
ORCL Oracle Corporation | -26.52% | 18.13% | 59.99% | 30.94% | -4.65% | 6.31% |
Correlation
The correlation between ALZN and ORCL is 0.14, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.14 |
Correlation (3Y) Balances recent behavior with more history. | 0.11 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.12 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2021 | 0.11 |
Fundamentals
ALZN:
$5.10M
ORCL:
$408.74B
ALZN:
-$1.96
ORCL:
$5.86
ALZN:
$0.00
ORCL:
$67.36B
ALZN:
$0.00
ORCL:
$79.58B
ALZN:
-$6.94M
ORCL:
$6.20B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ALZN vs. ORCL — Risk / Return Rank
ALZN
ORCL
ALZN vs. ORCL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Alzamend Neuro, Inc. (ALZN) and Oracle Corporation (ORCL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ALZN | ORCL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.10 | ||
| Sortino ratioReturn per unit of downside risk | +0.44 | ||
| Omega ratioGain probability vs. loss probability | 0.95 | 0.91 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | -0.58 | -0.64 | +0.06 |
| Martin ratioReturn relative to average drawdown | -1.08 | -1.01 | -0.08 |
Loading charts...
Drawdowns
ALZN vs. ORCL - Drawdown Comparison
The maximum ALZN drawdown since its inception was -100.00%, which is greater than ORCL's maximum drawdown of -84.19%. Use the drawdown chart below to compare losses from any high point for ALZN and ORCL.
Loading charts...
Drawdown Indicators
| ALZN | ORCL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -84.19% | -15.81% |
Max Drawdown (1Y)Largest decline over 1 year | -67.27% | -64.58% | -2.69% |
Max Drawdown (3Y)Largest decline over 3 years | -99.85% | -64.58% | -35.27% |
Max Drawdown (5Y)Largest decline over 5 years | -99.98% | -64.58% | -35.40% |
Max Drawdown (10Y)Largest decline over 10 years | — | -64.58% | — |
Current DrawdownCurrent decline from peak | -100.00% | -56.30% | -43.70% |
Average DrawdownAverage peak-to-trough decline | -97.57% | -29.20% | -68.37% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 36.12% | 41.05% | -4.93% |
Volatility
ALZN vs. ORCL - Volatility Comparison
The current volatility for Alzamend Neuro, Inc. (ALZN) is 13.27%, while Oracle Corporation (ORCL) has a volatility of 19.84%. This indicates that ALZN experiences smaller price fluctuations and is considered to be less risky than ORCL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ALZN | ORCL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.27% | 19.84% | -6.57% |
Volatility (6M)Calculated over the trailing 6-month period | 66.19% | 44.65% | +21.54% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.66% | 67.05% | +8.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 125.92% | 43.16% | +82.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 128.79% | 35.80% | +92.99% |
Dividends
ALZN vs. ORCL - Dividend Comparison
ALZN has not paid dividends to shareholders, while ORCL's dividend yield for the trailing twelve months is around 1.41%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALZN Alzamend Neuro, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ORCL Oracle Corporation | 1.41% | 0.97% | 0.96% | 1.44% | 1.57% | 1.38% | 1.48% | 1.72% | 1.68% | 1.52% | 1.56% | 1.56% |
Financials
ALZN vs. ORCL - Financials Comparison
This section allows you to compare key financial metrics between Alzamend Neuro, Inc. and Oracle Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ALZN and ORCL have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ORCL has higher volatility (19.84%) compared to ALZN (13.27%). In terms of maximum drawdown, ALZN dropped -100.00% vs ORCL's -84.19%.
ALZN currently has the higher Sharpe Ratio (-0.52 vs -0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ALZN and ORCL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer